Platelet-derived microparticles are implicated in remote ischemia conditioning in a rat model of cerebral infarction

CNS Neuroscience and Therapeutics

Volumn 19, Issue 12, 2013, Pages 917-925

  Shan, Li Yang ^a   Li, Ji Zhao ^b   Zu, Ling Yun ^c   Niu, Chen Guang ^b   Ferro, Albert ^d   Zhang, Ying Dong ^e   Zheng, Le Min ^c   Ji, Yong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Ischemic stroke; Microparticles; Per conditioning; Remote ischemic preconditioning

Indexed keywords

TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BRAIN INFARCTION; CONTROLLED STUDY; ISCHEMIC PRECONDITIONING; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLATELET MICROPARTICLE; RAT;

ISCHEMIC STROKE; MICROPARTICLES; PER-CONDITIONING; REMOTE ISCHEMIC PRECONDITIONING;

ANIMALS; CELL-DERIVED MICROPARTICLES; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FLOW CYTOMETRY; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC PRECONDITIONING; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NERVOUS SYSTEM DISEASES; PLATELET MEMBRANE GLYCOPROTEIN IIB; RATS; RATS, SPRAGUE-DAWLEY; UPPER EXTREMITY;

EID: 84888204046     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12199     Document Type: Article

References (41)

1. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 2008;79:377-386.
2. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 1994;168:221-224.
3. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996;94:2193-2200.
4. Shimizu M, Tropak M, Diaz RJ, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 2009;117:191-200.
5. Zhao H, Xiong LZ, Dong HL, et al. Protective effect of remote ischemic preconditioning against focal cerebral ischemia/reperfusion injury in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007;19:340-342.
6. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166-175.
7. Fan YY, Zhang XN, He P, et al. Transient lack of glucose but not O2 is involved in ischemic postconditioning-induced neuroprotection. CNS Neurosci Ther 2013;19:30-37.
8. Wei K, Wang P, Miao CY. A double-edged sword with therapeutic potential: an updated role of autophagy in ischemic cerebral injury. CNS Neurosci Ther 2012;18:879-886.
9. Martinez MC, Andriantsitohaina R. Microparticles in angiogenesis: therapeutic potential. Circ Res 2011;109:110-119.
10. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010;107:1047-1057.
11. Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011;108:1284-1297.
12. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011;31:27-33.
13. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005;67:30-38.
14. Hayon Y, Dashevsky O, Shai E, Brill A, Varon D, Leker RR. Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia. Curr Neurovasc Res 2012;9:185-192.
15. Hayon Y, Shai E, Varon D, Leker RR. The role of platelets and their microparticles in rehabilitation of ischemic brain tissue. CNS Neurol Disord Drug Targets 2012;11:921-925.
16. Hahn CD, Manlhiot C, Schmidt MR, Nielsen TT, Redington AN. Remote ischemic per-conditioning: a novel therapy for acute stroke? Stroke 2011;42:2960-2962.
17. Liu XR, Luo M, Yan F, et al. Ischemic postconditioning diminishes matrix metalloproteinase 9 expression and attenuates loss of the extracellular matrix proteins in rats following middle cerebral artery occlusion and reperfusion. CNS Neurosci Ther 2012;18:855-863.
18. van Bruggen N, Cullen BM, King MD, et al. T2- and diffusion-weighted magnetic resonance imaging of a focal ischemic lesion in rat brain. Stroke 1992;23:576-582.
19. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med 1985;26:72-76.
20. Flaumenhaft R, Dilks JR, Richardson J, et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009;113:1112-1121.
21. Robert S, Poncelet P, Lacroix R, et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 2009;7:190-197.
22. Robert S, Lacroix R, Poncelet P, et al. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles-brief report. Arterioscler Thromb Vasc Biol 2012;32:1054-1058.
23. Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001;32:1005-1011.
24. Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001;32:2682-2688.
25. Cherian P, Hankey GJ, Eikelboom JW, et al. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 2003;34:2132-2137.
26. Serebruany VL, Malinin AI, Ziai W, et al. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial. Stroke 2005;36:2289-2292.
27. Pawelczyk M, Baj Z, Chmielewski H, Kaczorowska B, Klimek A. The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke. Cerebrovasc Dis 2009;27:131-137.
28. Sinning JM, Losch J, Walenta K, Bohm M, Nickenig G, Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011;32:2034-2041.
29. Bernal-Mizrachi L, Jy W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003;145:962-970.
30. Horstman LL, Jy W, Bidot CJ, et al. Potential roles of cell-derived microparticles in ischemic brain disease. Neurol Res 2009;31:799-806.
31. Cantaluppi V, Gatti S, Medica D, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int 2012;82:412-427.
32. Jung KH, Chu K, Lee ST, et al. Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol 2009;66:191-199.
33. Kisucka J, Chauhan AK, Zhao BQ, et al. Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 2009;113:6015-6022.
34. Kunder CA, St John AL, Li G, et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med 2009;206:2455-2467.
35. Jeanneteau J, Hibert P, Martinez MC, et al. Microparticle release in remote ischemic conditioning mechanism. Am J Physiol Heart Circ Physiol 2012;303:H871-877.
36. Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010;77:502-514.
37. Shefler I, Salamon P, Reshef T, Mor A, Mekori YA. T cell-induced mast cell activation: a role for microparticles released from activated T cells. J Immunol 2010;185:4206-4212.
38. Jansen F, Yang X, Hoyer FF, et al. Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis. Arterioscler Thromb Vasc Biol 2012;32:1925-1935.
39. Admyre C, Johansson SM, Qazi KR, et al. Exosomes with immune modulatory features are present in human breast milk. J Immunol 2007;179:1969-1978.
40. Redman CW, Tannetta DS, Dragovic RA, et al. Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 2012;33(Suppl):S48-54.
41. Montoro-Garcia S, Shantsila E, Tapp LD, et al. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis 2013;227:313-322.